Table 2—

Diabetes and its current treatment among case and control subjects

Case subjects (462)Control subjects (1,781)OR95% CI
Diabetes27 (5.8)55 (3.1)1.91.2–3.1
Diet treatment only6 (1.3)11 (0.6)2.10.8–5.1
Glyburide only10 (2.2)13 (0.7)3.01.3–6.9
Glyburide and metformin3 (0.6)2 (0.1)5.81.0–34.9
Glyburide and insulin0 (0.0)1 (0.06)NA
Glimeperide only1 (0.2)4 (0.2)1.00.1–8.6
Glipizide only0 (0.0)5 (0.3)NA
Glipizide and metformin1 (0.2)2 (0.1)1.90.2–21.3
Glipizide and insulin0 (0.0)1 (0.06)NA
Metformin only0 (0.0)1 (0.1)NA
Insulin only5 (1.1)14 (0.8)1.40.5–3.9
Insulin and metformin1 (0.2)1 (0.1)3.90.2–61.9
Glyburide and any other antidiabetic13 (2.8)16 (0.9)3.21.5–6.7
Glipizide and any other antidiabetic1 (0.2)8 (0.4)0.50.1–3.9
Metformin and any other antidiabetic5 (1.1)6 (0.3)3.21.0–10.7
Insulin and any other antidiabetic6 (1.3)17 (1.0)1.40.5–3.5
Glyburide, not metformin10 (2.2)14 (0.8)2.81.2–6.3
Metformin, not glyburide2 (0.4)4 (0.2)1.90.4–10.6
  • Data are frequency (%) unless otherwise indicated. NA, not analyzed.